Skip to main content
. 2021 Jul 7;49(1):44–61. doi: 10.1159/000516886

Fig. 4.

Fig. 4

Stimulatory effect of DC/DCleu on the cytotoxic activity of immunoreactive cells as measured by CTX. Given are the proportions of cases with blast lysis (“% cases with blast lysis”) and the mean ± range of lysed blasts (“% lysed blasts”) in WBDC(I)-MLC, WBDC(M)-MLC, and WBDC(Control)-MLC after 3 h (A) and 24 h (C), and the “best” achieved blast lysis after 3 h or 24 h (E); the proportions of cases with an improvement in blast lysis (“% cases with improved blast lysis”) and the mean ± range of improved lysed blasts (“% improved lysed blasts”) in WBDC(I)-MLC and WBDC(M)-MLC in relation to WBDC(Control)-MLC after 3 h (B) and 24 h (D), and the “best” achieved improvement in blast lysis after 3 h or 24 h (F).